Applications of Nanotechnology in Medical Examination and Therapy

A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".

Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 3538

Special Issue Editors


E-Mail Website
Guest Editor
1. Center of Applied Nanomedicine, National Cheng Kung University, Tainan 701, Taiwan
2. Department of Oncology, College of Medicine and Hospital, National Cheng Kung University, Tainan 701, Taiwan
Interests: nanomedicine; clinical trial; lung cancer; tumor biology; signal transduction

E-Mail Website
Guest Editor Assistant
1. Center of Applied Nanomedicine, National Cheng Kung University, Tainan 701, Taiwan
2. Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan 701, Taiwan
Interests: nanomedicine; translational medicine; tumor biology; molecular and cellular biology

Special Issue Information

Dear Colleagues,

Nanomaterials are extensively explored in biomedical applications and open up new areas of molecular imaging, drug delivery, and various tumor therapeutic modalities, as well as vaccine development. In addition to human-made nanomaterials, naturally occurring nanomaterials such as the extracellular vesicles play important roles in physiological and pathological conditions of human diseases and have potential for diagnostic and therapeutic applications. Despite the numerous promising preclinical studies which have been reported, the number of approved nanomedicine products for clinical use is relatively small. Thus, this Special Issue aims to provide an up-to-date collection of original research articles and review papers of the exciting and fast-growing field Applications of Nanotechnology in Medical Examination and Therapy. In this collection, clinical translation of nanomedicine will be emphasized. In view of your outstanding research in this field, we are pleased to invite you to contribute to this Special Issue and submit your excellent works of the associated topics. We look forward to receiving your contributions.

Thank you.

Prof. Dr. Wu-Chou Su
Guest Editor

Dr. Allen Wei-Lun Huang
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanotechnology
  • medical examination/diagnosis
  • targeted therapy
  • photodynamic therapy
  • photothermal therapy
  • theranostics
  • nanomedicine
  • extracellular vesicles
  • drug and gene delivery
  • molecular imaging
  • tissue engineering
  • nanoimmunology

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

12 pages, 4824 KiB  
Article
A Trilayer Dressing with Self-Pumping and pH Monitoring Properties for Promoting Abdominal Wall Defect Repair
by Jie Hu, Guopu Chen and Gefei Wang
Nanomaterials 2022, 12(16), 2802; https://doi.org/10.3390/nano12162802 - 15 Aug 2022
Cited by 6 | Viewed by 1902
Abstract
Due to abdominal infection, excessive wound exudation, and intestinal fistula formation, the treatment of full-thickness abdominal wall defects has become a difficult challenge for clinic doctors. This clinical problem cannot be resolved with existing biomaterials. To facilitate the repair of the abdominal wall, [...] Read more.
Due to abdominal infection, excessive wound exudation, and intestinal fistula formation, the treatment of full-thickness abdominal wall defects has become a difficult challenge for clinic doctors. This clinical problem cannot be resolved with existing biomaterials. To facilitate the repair of the abdominal wall, we developed a novel wound dressing with directional biofluid transport. We used electrospinning to spin a trilayer dressing consisting of hydrolyzed poly-acrylonitrile (HPAN)/Curcumin (CUR), polyurethane (PU), and polycaprolactone (PCL). In vitro results show that the three-layer wound dressing is biocompatible, capable of directional transport of excessive wound exudation, preventing reverse penetration, and monitoring the pH of the wound. Furthermore, in vivo results show the trilayer wound dressing improves the wound microenvironment, reduces inflammatory factors, promotes angiogenesis, and accelerates abdominal wall repair. Thus, we believe that the novel trilayer electrospinning dressing could facilitate abdominal wall defect repair. Full article
(This article belongs to the Special Issue Applications of Nanotechnology in Medical Examination and Therapy)
Show Figures

Figure 1

Review

Jump to: Research

18 pages, 1106 KiB  
Review
The Roles of Extracellular Vesicles in the Progression of Renal Cell Carcinoma and Their Potential for Future Clinical Application
by Masashi Takeda, Shusuke Akamatsu, Yuki Kita, Takayuki Goto and Takashi Kobayashi
Nanomaterials 2023, 13(10), 1611; https://doi.org/10.3390/nano13101611 - 11 May 2023
Cited by 1 | Viewed by 2367
Abstract
Renal cell carcinoma (RCC) is the most common type of kidney cancer and is thought to originate from renal tubular epithelial cells. Extracellular vesicles (EVs) are nanosized lipid bilayer vesicles that are secreted into extracellular spaces by nearly all cell types, including cancer [...] Read more.
Renal cell carcinoma (RCC) is the most common type of kidney cancer and is thought to originate from renal tubular epithelial cells. Extracellular vesicles (EVs) are nanosized lipid bilayer vesicles that are secreted into extracellular spaces by nearly all cell types, including cancer cells and non-cancerous cells. EVs are involved in multiple steps of RCC progression, such as local invasion, host immune modulation, drug resistance, and metastasis. Therefore, EVs secreted from RCC are attracting rapidly increasing attention from researchers. In this review, we highlight the mechanism by which RCC-derived EVs lead to disease progression as well as the potential and challenges related to the clinical implications of EV-based diagnostics and therapeutics. Full article
(This article belongs to the Special Issue Applications of Nanotechnology in Medical Examination and Therapy)
Show Figures

Figure 1

Back to TopTop